Is ResMed (RMD) overvalued or fairly valued?

MarketChacha shows ResMed's valuation in context — a forward P/E of about 16.1, a price-to-book of about 4.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of ResMed (RMD)?

ResMed last traded at $194.00 (-0.9% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

ResMed

RMD · NYSE · Healthcare · United States

$194.00-0.9%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:35 PM

Snapshot

TickerRMD

ExchangeNYSE

SectorHealthcare

IndustryMedical Instruments & Supplies

CountryUnited States

Employees10,600

HeadquartersSan Diego, United States

Market cap$28.1B

P/B4.3

Volume326.65K

Websitewww.resmed.com

Filings tracked0

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.5%
Institutions70.0%
Public & other29.5%

1,400 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.8.34%
Vanguard Capital Management LLC6.53%
Vanguard Portfolio Management LLC5.42%
State Street Corporation4.58%
Bank Of New York Mellon Corporation3.40%
Geode Capital Management, LLC3.00%
Morgan Stanley1.85%
Invesco Ltd.1.35%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $1.4B · EPS 2.84

Est. earnings growth +11.3%

Next fiscal year

Rev $6.0B · EPS 12.05

Est. earnings growth +8.5%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$180.2752-wk range$293.81

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about RMD

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.